Barbara Meissner
Hannover, NI 30625, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Decreasing excess mortality after allogeneic stem cell transplantation for acute leukemia.
Journal: Haematologica
Published: April 23, 2026
Survival Trends in Young Adults With Acute Leukaemia After AHSCT in Germany: Comparisons With Younger and Older Patients.
Journal: Transplantation and cellular therapy
Published: February 16, 2026
Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression.
Journal: Bone marrow transplantation
Published: June 05, 2023
Relapse of a group 4 medulloblastoma after 18 years as proven by histology and DNA methylation profiling.
Journal: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
Published: December 28, 2018
ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1 deletion in childhood acute lymphoblastic leukemia.
Journal: Leukemia
Published: May 07, 2015
ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1 deletion in childhood acute lymphoblastic leukemia.
Journal: Leukemia
Published: September 28, 2013
Frequent and sex-biased deletion of SLX4IP by illegitimate V(D)J-mediated recombination in childhood acute lymphoblastic leukemia.
Journal: Human molecular genetics
Published: September 19, 2013
IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.
Journal: Haematologica
Published: August 10, 2012
Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.
Journal: Pediatric blood & cancer
Published: March 07, 2012
Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemia.
Journal: Haematologica
Published: January 25, 2012
Last Updated: 09/26/2026